Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma

This publication has 18 references indexed in Scilit:

• Anti-allergic drug use in Japan-the rationale and the clinical outcome
  Clinical and Experimental Allergy, 1994
• Inhibitory Effect of a Thromboxane A2 Synthetase Inhibitor OKY-046 on Bronchial Hyperresponsiveness to Histamine, but not on Airway Wall Thickening, Induced by Intravenous Administration of Leukotriene C4 in Guinea-pigs
  Pulmonary Pharmacology, 1993
• A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
  Journal of Allergy and Clinical Immunology, 1992
• Plasma Prostaglandin Levels from Bronchial Asthmatic Patients Assayed by 9-Anthryldiazomethane-HPLC Method
  Journal of Asthma, 1990
• Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.
  Thorax, 1986
• Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U46619
  European Journal of Pharmacology, 1985
• Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects
  Journal of Allergy and Clinical Immunology, 1982
• Thromboxane generation by human peripheral blood polymorphonuclear leukocytes.
  The Journal of Experimental Medicine, 1978
• Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides
  Nature, 1976
• Terminology, Definitions, and Classification of Chronic Pulmonary Emphysema and Related Conditions: A REPORT OF THE CONCLUSIONS OF A CIBA GUEST SYMPOSIUM
  Thorax, 1959